To begin, epidemiologists in India frequently publish prevalence and incidence studies to guide public health policies. Consequently, improving the quality of reporting observational studies remains a top priority for clinical researchers. Specifically, the original STROBE framework lacked key details for tracking disease metrics. To solve this, a global expert panel recently introduced the STROBE EPIC extension. Therefore, researchers can now design and document their studies with significantly greater precision.
The Importance of Reporting Observational Studies
Previously, authors faced difficulties because the original STROBE statement lacked specific reporting items for disease prevalence and incidence. Indeed, researchers had to modify general templates, which often led to incomplete datasets. Moreover, policy makers need precise incidence data to allocate public health resources effectively. Consequently, this gap created inconsistencies in global medical literature. Thus, the STROBE EPIC guideline directly addresses these systematic shortcomings.
How Experts Developed the EPIC Extension
First, the development team followed established methodology carefully. Subsequently, they generated a comprehensive initial list of potential reporting items. Furthermore, they conducted a modified Delphi process and held a consensus meeting to refine these concepts. In addition, they executed two additional Delphi rounds to expand the scope. Because of these efforts, the checklist now covers all infectious diseases, noncommunicable diseases, and injuries. Finally, experts successfully piloted the draft checklist on real manuscripts to ensure clinical utility.
Key Components of the STROBE EPIC Checklist
As structured, the final checklist comprises exactly 47 detailed items across seven distinct scientific domains. In particular, the methods section contains 25 items to ensure deep analytical transparency. Additionally, the results and discussion domains include six and seven items, respectively. Moreover, the checklist mandates thorough reporting on denominator population estimation and case ascertainment methods. As a result, authors must explicitly describe factors that produce artificial changes to observed disease metrics. Ultimately, this level of detail dramatically improves data reliability.
Why Indian Researchers Must Adopt This Standard
Indeed, Indian health researchers routinely study massive populations with high burdens of infectious and chronic diseases. Therefore, utilizing the STROBE EPIC criteria will significantly enhance the international credibility of Indian medical publications. Furthermore, major global journals will likely require these standards for future peer reviews. As a result, adopting this checklist will prevent common rejection reasons related to ambiguous denominator estimations. Thus, local medical societies must actively promote this checklist to advance national scientific excellence.
Frequently Asked Questions
Q1: What is the main purpose of the STROBE EPIC extension?
Specifically, the extension provides specific reporting items for observational studies focusing on disease prevalence and incidence. As a result, this framework helps researchers present clear and robust epidemiologic evidence.
Q2: How many items does the STROBE EPIC checklist contain?
Specifically, the checklist comprises 47 items distributed across seven primary sections. Additionally, these domains cover everything from methods to results.
Q3: Why is this guideline important for medical editors?
Indeed, it allows journal editors and peer reviewers to evaluate observational research easily. Therefore, editors can quickly spot gaps in data reporting.
References
- Murthy S et al. Strengthening the Reporting of Observational Studies in Epidemiology Enhanced Prevalence and Incidence Criteria (STROBE EPIC): An Extension of the STROBE Statement. Ann Intern Med. 2026 Jul 21. doi: 10.7326/ANNALS-25-02412. PMID: 42475690.
- von Elm E et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573-577. PMID: 17938396.